ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag business biotech nonprofit clinical trials

The Profits of Nonprofit
Megan Scudellari | Jan 1, 2011 | 7 min read
The surprising results when drug development and altruism collide
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Clinical Trial Reversals Forcing Biotech Firms To Refine Strategy
Susan Dickinson | Sep 18, 1994 | 7 min read
Under pressure to reap return on investment, companies are seeking ways to ensure success in designing drug tests This past July, Synergen Inc. suspended clinical trials of its anti-inflammatory drug candidate, Antril--being tested to fight sepsis--for lack of efficacy. Faced with the setback to its $100 million-plus investment, the Boulder, Colo.-based biotech was forced to lay off more than half its work force and shut down two
Clinical Trial Reversals Forcing Biotech Firms To Refine Strategy
Susan Dickinson | Sep 18, 1994 | 7 min read
Under pressure to reap return on investment, companies are seeking ways to ensure success in designing drug tests This past July, Synergen Inc. suspended clinical trials of its anti-inflammatory drug candidate, Antril--being tested to fight sepsis--for lack of efficacy. Faced with the setback to its $100 million-plus investment, the Boulder, Colo.-based biotech was forced to lay off more than half its work force and shut down two
Synthetic Bacteria Help Treat Phenylketonuria in Mice
Diana Kwon | Aug 17, 2018 | 2 min read
The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.
The Profits of Nonprofit
Megan Scudellari | Jan 1, 2011 | 7 min read
By Megan Scudellari The Profits of Nonprofit The surprising results when drug development and altruism collide Victoria Hale, founder of the Institute of OneWorld Health, the first nonprofit pharmaceutical company in the US POPTECH In the beginning, they called her a fool. When pharmaceutical chemist Victoria Hale told friends and colleagues that she wanted to start a nonprofit pharma company, they laughed at her, said it was career suicide, that it could
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Start It Up
Dan Cossins | Apr 1, 2013 | 8 min read
Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
WELCOMING BIOTECH WITH OPEN ARMS
David Schoonmaker | Apr 1, 2007 | 4 min read
By David SchoonmakerWELCOMING BIOTECH WITH OPEN ARMSThrough the North Carolina Biotechnology Center, the Tarheel State encourages industry investment. In 1984, biotechnology was anything but a household word, especially in North Carolina. Nonetheless, a group of Tarheel visionaries saw the future as it might be and set about to make it happen. The North Carolina Biotechnology Center was created that year by the state legislature as the nation's first private, nonprofit organization to further
When the Line Between Science and Business Blurs
Ted Agres(tagres@the-scientist.com) | Feb 27, 2005 | 6 min read
In 2004, media reports and US congressional investigations revealed that dozens of intramural scientists and officials at the National Institutes of Heath had received substantial amounts of cash and stock options by consulting with drug and biotech companies, many of which had dealings with the agency.

Run a Search

ADVERTISEMENT